(2024) Compare and contrast the glucagon-like peptide-1 receptor agonists FDA (2023) Prescribing Information, Saxenda FDA (2023) Prescribing Information, Ozempic Novo Nordisk (2025) Ozempic Savings Offer Novo Nordisk (2025) Wegovy Supply Update Novo Nordisk (2025) Rybelsus Savings & Support Novo Nordisk (2025) Saxenda Savings Program Novo Nordisk (2025) Victoza Coverage & Reimbursement FAQs Novo Nordisk
As always, discuss any new medications with your healthcare provider
The effects of GLP-1 receptor agonists on inhibition of food intake and body weight loss are currently of considerable interest (118)
Always consult with a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medications, or have an underlying medical condition.
Popular GLP-1 Receptor Agonists Some of the well-known GLP-1 receptor agonists include: There are four GLP-1 agonist medicines approved by the Therapeutic Goods Administration (TGA) for use in Australia for the management of Type 2 Diabetes: dulaglutide (Trulicity) semaglutide (Ozempic) tirzepatide (Mounjaro) liraglutide (Saxenda)